Neuralieve, in stealth mode, creates devices to treat migraine headaches. NeuraLieve developes transcutaneous magnetic stimulation to relieve migraines and other headaches.
Financials
| Date | Type | Amount | Investors | Valuation |
|---|---|---|---|---|
| 10/31/05 | Series B | 5M | Unknown |
People
Robert Fischell (CTO)
Lorine Tanimoto (Director of Clinical Operations)
Ting Lu (CFO)
Annette Campbell-White (Board member)
News
Neuralieve brings in $3.9M for non-invasive neurological treatments
January 12, 2010 6:54 am
Neuralieve, maker of a portable, non-invasive device used to treat neurological problems, particularly migraines, has brought in $3.9 million of… Continue reading ⟩